Precision Medicine Made Practical with Kara Werner
Episode Overview
Tempus AI's mission to make patient data meaningful. Kara Werner's career journey from Kellogg to Tempus. The impact of AI on precision medicine and diagnostics. Advice for MBAs entering the healthtech space. Personal experiences driving healthcare innovation.
I think we've done a nice job of partnering with a number of companies to continue to add on more tests to our platform.
In this episode of Kellogg Healthscape, host Ashley Lemon, an MBA student at Northwestern Kellogg, sits down with Kara Werner, Vice President and General Manager of Life Sciences Research at Tempus AI. Tempus AI, a company founded in 2015 and recently IPO'd, is at the forefront of integrating AI-enabled precision medicine into healthcare by leveraging the world's largest library of clinical and molecular data.
Kara shares her professional journey, starting from her time at Kellogg, where she was deeply influenced by her experiences in consulting and healthtech. Her initial stint at Accenture focused on life sciences strategy, which laid the foundation for her eventual move to Tempus. The Kellogg Healthcare Conference played a pivotal role in introducing Kara to Tempus and its mission, which resonated with her passion for improving healthcare systems.
The conversation delves into how Tempus utilizes AI to transform patient data into actionable insights, enabling earlier cancer diagnoses and making precision medicine more accessible. Kara explains how partnerships with companies like NeoGenomics and Personalis have expanded Tempus's diagnostic capabilities. She highlights the significant advancements in AI that have accelerated innovation within the company, particularly in the realm of RNA and DNA sequencing. Kara also offers invaluable advice for MBA students aspiring to enter the healthtech sector.
She emphasizes the importance of personal experiences in shaping one's career path and the need to leverage technology to solve real-world healthcare challenges. Her insights into Tempus's strategic approach to data utilization underscore the company's commitment to improving patient outcomes. Towards the end of the discussion, Kara shares a lighter side of herself, expressing her love for travel and her dream of becoming a travel agent, showcasing her multifaceted interests beyond her professional role.
Overall, this episode provides a comprehensive overview of how Tempus AI is leading the charge in precision medicine, while also offering practical career advice for those looking to make an impact in the healthtech industry.